tldrdailynews.com logo

"China Greenlights AstraZeneca and Sanofi's Beyfortus for Infant RSV Prevention"

1 min read
Source: Bloomberg
TL;DR

Users attempting to access a Bloomberg page were presented with a message questioning if they are a robot, which typically occurs due to issues with JavaScript, cookies, or specific browser settings that prevent proper page loading. The message suggests ensuring browser compatibility and reviewing the Terms of Service and Cookie Policy for more information, while also offering a contact option for further assistance, indicating a standard security measure to protect the website's content.

Topics:healthtechnologyweb##bloomberg#browsersupport#cookies#robotcheck#technicalissue#technologyweb
Share this article
  1. China Approves AstraZeneca, Sanofi Shot to Prevent RSV Infection  Bloomberg
  2. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants | NEJM  nejm.org
  3. AstraZeneca, Sanofi RSV infant shots approved in China  Reuters.com
  4. RSV vaccines would greatly reduce illness if implemented like flu shots, research suggests  Medical Xpress
  5. China signs off on AZ, Sanofi's RSV shot Beyfortus for infants  FiercePharma

Want the full story? Read the original reporting

Read on Bloomberg